"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells

BackgroundHuman stem cells are viewed as a possible source of neurons for a cell-based therapy of neurodegenerative disorders, such as Parkinson's disease. Several protocols that generate different types of neurons from human stem cells (hSCs) have been developed. Nevertheless, the cellular mechanisms that underlie the development of neurons in vitro as they are subjected to the specific differentiation protocols are often poorly understood.ResultsWe have designed a focused DNA (oligonucleotide-based) large-scale microarray platform (named "NeuroStem Chip") and used it to study gene expression patterns in hSCs as they differentiate into neurons. We have selected genes that are relevant to cells (i) being stem cells, (ii) becoming neurons, and (iii) being neurons. The NeuroStem Chip has over 1,300 pre-selected gene targets and multiple controls spotted in quadruplicates (~46,000 spots total). In this study, we present the NeuroStem Chip in detail and describe the special advantages it offers to the fields of experimental neurology and stem cell biology. To illustrate the utility of NeuroStem Chip platform, we have characterized an undifferentiated population of pluripotent human embryonic stem cells (hESCs, cell line SA02). In addition, we have performed a comparative gene expression analysis of those cells versus a heterogeneous population of hESC-derived cells committed towards neuronal/dopaminergic differentiation pathway by co-culturing with PA6 stromal cells for 16 days and containing a few tyrosine hydroxylase-positive dopaminergic neurons.ConclusionWe characterized the gene expression profiles of undifferentiated and dopaminergic lineage-committed hESC-derived cells using a highly focused custom microarray platform (NeuroStem Chip) that can become an important research tool in human stem cell biology. We propose that the areas of application for NeuroStem microarray platform could be the following: (i) characterization of the expression of established, pre-selected gene targets in hSC lines, including newly derived ones, (ii) longitudinal quality control for maintained hSC populations, (iii) following gene expression changes during differentiation under defined cell culture conditions, and (iv) confirming the success of differentiation into specific neuronal subtypes.

[1]  K. Boheler,et al.  SAGE identification of differentiation responsive genes in P19 embryonic cells induced to form cardiomyocytes in vitro , 2002, Mechanisms of Development.

[2]  Mahendra S Rao,et al.  In search of "stemness". , 2004, Experimental hematology.

[3]  P. Brundin,et al.  Stem cell therapy for Parkinson’s disease: where do we stand? , 2004, Cell and Tissue Research.

[4]  R. Dingledine,et al.  Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism , 2005, Neurobiology of Disease.

[5]  C. Shun,et al.  Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. , 2007, Human reproduction.

[6]  Ji-yeon Lee,et al.  In vitro and in vivo analyses of human embryonic stem cell‐derived dopamine neurons , 2005, Journal of neurochemistry.

[7]  S. V. Anisimov,et al.  SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. , 2002, Genomics.

[8]  A. Hampl,et al.  Expression and Potential Role of Fibroblast Growth Factor 2 and Its Receptors in Human Embryonic Stem Cells , 2005, Stem cells.

[9]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[10]  Jerry Li,et al.  Within the fold: assessing differential expression measures and reproducibility in microarray assays , 2002, Genome Biology.

[11]  Xueying Gu,et al.  Differentiation of Insulin-Producing Cells from Human Neural Progenitor Cells , 2005, PLoS medicine.

[12]  C. Olanow,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[13]  O. Lindvall,et al.  Stem cell therapy for human neurodegenerative disorders–how to make it work , 2004, Nature Medicine.

[14]  V. Tabar,et al.  Derivation of midbrain dopamine neurons from human embryonic stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Brundin,et al.  Stem cell‐based therapy for Parkinson's disease , 2005, Annals of medicine.

[16]  R. Barber,et al.  GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. , 2005, Physiological genomics.

[17]  R. Lothe,et al.  Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. , 2005, Cancer research.

[18]  M. Katoh,et al.  Comparative genomics on BMP4 orthologs. , 2005, International Journal of Oncology.

[19]  R. Puri,et al.  Development of a focused microarray to assess human embryonic stem cell differentiation. , 2005, Stem cells and development.

[20]  P. Hegde,et al.  The Institute for Genomic Research , 1998, Current Biology.

[21]  David Botstein,et al.  BMC Genomics BioMed Central Methodology article Universal Reference RNA as a standard for microarray experiments , 2004 .

[22]  T. Ben-Hur.  Human embryonic stem cell therapy for Parkinson's disease , 2006 .

[23]  A. Lindahl,et al.  Derivation, Characterization, and Differentiation of Human Embryonic Stem Cells , 2004, Stem cells.

[24]  W. Cleveland,et al.  Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .

[25]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[26]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[27]  S. Baker,et al.  NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. , 2005, Stem cells and development.

[28]  M. Brownstein,et al.  Comprehensive transcriptome analysis of differentiation of embryonic stem cells into midbrain and hindbrain neurons. , 2004, Developmental biology.

[29]  O. Lindvall,et al.  Clinical observations after neural transplantation in Parkinson's disease. , 2000, Progress in brain research.

[30]  J. Thomson,et al.  Basic Fibroblast Growth Factor Support of Human Embryonic Stem Cell Self‐Renewal , 2006, Stem cells.

[31]  P. Rathjen,et al.  Sequence, Genomic Organization, and Expression of the Novel Homeobox Gene Hesx1(*) , 1995, The Journal of Biological Chemistry.

[32]  D. O'Leary,et al.  Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta , 2004, Molecular and Cellular Neuroscience.

[33]  Ling Lin,et al.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. , 2005, Human molecular genetics.

[34]  Kenji Mizuseki,et al.  Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Grimm,et al.  Molecular basis for catecholaminergic neuron diversity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Mummery,et al.  Fibroblast Growth Factor-Mediated Growth Regulation and Receptor Expression in Embryonal Carcinoma and Embryonic Stem Cells and Human Germ Cell Tumors , 1993 .

[37]  S. V. Anisimov,et al.  Application of DNA microarray technology to gerontological studies. , 2007, Methods in molecular biology.

[38]  Ornella Rimoldi,et al.  Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient , 1999, Nature Neuroscience.

[39]  P. Rathjen,et al.  Hesx1, a homeobox gene expressed by murine embryonic stem cells, maps to mouse chromosome 14, bands A3-B. , 1993, Genomics.

[40]  M. Herlyn,et al.  Isolation of a novel population of multipotent adult stem cells from human hair follicles. , 2006, The American journal of pathology.

[41]  K. Mizuseki,et al.  Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.

[42]  Z. Grossman,et al.  A non-programmatic approach to hemopoiesis. , 1986, Progress in clinical and biological research.

[43]  Vesna Sossi,et al.  A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.

[44]  A. Sandford,et al.  Selection of reference genes for gene expression studies in human neutrophils by real-time PCR , 2005, BMC Molecular Biology.

[45]  M. Rao,et al.  A Focused Microarray to Assess Dopaminergic and Glial Cell Differentiation from Fetal Tissue or Embryonic Stem Cells , 2006, Stem cells.

[46]  W. Freed,et al.  Dopaminergic Differentiation of Human Embryonic Stem Cells , 2004, Stem cells.

[47]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[48]  N. Blom,et al.  Identification of novel genes regulated in the developing human ventral mesencephalon , 2006, Experimental Neurology.

[49]  S. Gruvberger,et al.  BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data , 2002, Genome Biology.

[50]  R. Puri,et al.  Gene expression in human embryonic stem cell lines: unique molecular signature. , 2004, Blood.

[51]  M. Morris,et al.  Reconstructive neurosurgery for Parkinson’s disease: a systematic review and preliminary meta-analysis , 2003, Brain Research Bulletin.